Cite

    Yoshino, Y. et al. (2020). Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients. Journal of obstetrics and gynaecology research. 46 (12), pp. 2662-2671. [Online].